Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

BACKGROUND: The dynamic change in C-reactive protein (CRP) levels, CRP kinetics, is a prognostic factor for metastatic renal cell carcinoma (mRCC) in the tyrosine kinase inhibitor era. We investigated the impact of early CRP kinetics on the efficacy of nivolumab in patients with mRCC. METHODS: We pe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Fukuda, Shohei, Saito, Kazutaka, Yasuda, Yosuke, Kijima, Toshiki, Yoshida, Soichiro, Yokoyama, Minato, Ishioka, Junichiro, Matsuoka, Yoh, Kageyama, Yukio, Fujii, Yasuhisa
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Immunotherapy Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7896625/
https://ncbi.nlm.nih.gov/pubmed/33602695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001564
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars